The Infusion Providers Alliance is pleased to submit testimony to the Ways & Means Health SubcommitteeInfusion Providers Alliance2025-04-21T16:35:06+00:00
New study highlights inadvertent impact of the Inflation Reduction Act: payment cuts of $25B-$37B to nonhospital physiciansInfusion Providers Alliance2024-09-19T20:59:25+00:00
The Infusion Providers Alliance is pleased to provide comments to CMS’ 2025 Medicare physician fee schedule proposed ruleInfusion Providers Alliance2024-09-10T13:26:06+00:00
IPA joins 45 providers and patient advocates in letter to CMS addressing access to certain biosimilar drug treatmentsInfusion Providers Alliance2024-09-10T13:29:24+00:00
The IPA strongly opposes a forthcoming “Medicaid price stacking” proposed rule (CMS-2434-P) that would impose large financial burdens on infusion providers still reeling from lack of liquidity due to the recent Change Healthcare cyber attack.Infusion Providers Alliance2024-04-02T20:32:35+00:00
